Recode Therapeutics, Inc. announced it raised $160 Million in an amended filing from an offering of $200 Million
Jul 06, 2022•about 3 years ago
Amount Raised
$160 Million
Menlo ParkBiotechnologyHealth Care
Company Information
Company
ReCode Therapeutics
Location
1455 ADAMS DRIVE
Menlo Park, California, United States
About
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.
Menlo Park